AMPHASTAR PHARMACEUTICALS IN (AMPH)
US03209R1032 - Common Stock
AMPH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. While AMPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on AMPH. These ratings could make AMPH a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year AMPH was profitable.
In the past year AMPH had a positive cash flow from operations.
AMPH had positive earnings in each of the past 5 years.
In the past 5 years AMPH always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.21%, AMPH belongs to the top of the industry, outperforming 93.19% of the companies in the same industry.
With an excellent Return On Equity value of 21.67%, AMPH belongs to the best of the industry, outperforming 93.72% of the companies in the same industry.
AMPH has a Return On Invested Capital of 12.46%. This is amongst the best in the industry. AMPH outperforms 91.10% of its industry peers.
AMPH had an Average Return On Invested Capital over the past 3 years of 11.94%. This is significantly below the industry average of 43.18%.
The 3 year average ROIC (11.94%) for AMPH is below the current ROIC(12.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.21% | ||
| ROE | 21.67% | ||
| ROIC | 12.46% |
ROA(3y)10.22%
ROA(5y)7.84%
ROE(3y)17.58%
ROE(5y)13.18%
ROIC(3y)11.94%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of AMPH (21.80%) is better than 94.24% of its industry peers.
AMPH's Profit Margin has improved in the last couple of years.
The Operating Margin of AMPH (29.61%) is better than 93.72% of its industry peers.
In the last couple of years the Operating Margin of AMPH has grown nicely.
AMPH's Gross Margin of 52.98% is fine compared to the rest of the industry. AMPH outperforms 62.30% of its industry peers.
AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.61% | ||
| PM (TTM) | 21.8% | ||
| GM | 52.98% |
OM growth 3Y114.39%
OM growth 5YN/A
PM growth 3Y276.41%
PM growth 5YN/A
GM growth 3Y10.26%
GM growth 5Y8.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMPH is creating some value.
Compared to 1 year ago, AMPH has about the same amount of shares outstanding.
AMPH has more shares outstanding than it did 5 years ago.
AMPH has a worse debt/assets ratio than last year.
2.2 Solvency
AMPH has an Altman-Z score of 3.10. This indicates that AMPH is financially healthy and has little risk of bankruptcy at the moment.
AMPH's Altman-Z score of 3.10 is fine compared to the rest of the industry. AMPH outperforms 74.87% of its industry peers.
AMPH has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as AMPH would need 3.51 years to pay back of all of its debts.
AMPH has a better Debt to FCF ratio (3.51) than 90.58% of its industry peers.
AMPH has a Debt/Equity ratio of 0.82. This is a neutral value indicating AMPH is somewhat dependend on debt financing.
The Debt to Equity ratio of AMPH (0.82) is worse than 70.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 3.1 |
ROIC/WACC1.32
WACC9.41%
2.3 Liquidity
AMPH has a Current Ratio of 3.43. This indicates that AMPH is financially healthy and has no problem in meeting its short term obligations.
AMPH has a Current ratio (3.43) which is comparable to the rest of the industry.
A Quick Ratio of 2.61 indicates that AMPH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.61, AMPH is in line with its industry, outperforming 51.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.43 | ||
| Quick Ratio | 2.61 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 21.27% over the past year.
AMPH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 70.36% yearly.
The Revenue has grown by 20.33% in the past year. This is a very strong growth!
Measured over the past years, AMPH shows a quite strong growth in Revenue. The Revenue has been growing by 16.94% on average per year.
EPS 1Y (TTM)21.27%
EPS 3Y72.76%
EPS 5Y70.36%
EPS Q2Q%-16.52%
Revenue 1Y (TTM)20.33%
Revenue growth 3Y22.59%
Revenue growth 5Y16.94%
Sales Q2Q%5.9%
3.2 Future
Based on estimates for the next years, AMPH will show a small growth in Earnings Per Share. The EPS will grow by 6.54% on average per year.
The Revenue is expected to grow by 8.30% on average over the next years. This is quite good.
EPS Next Y20.24%
EPS Next 2Y14.54%
EPS Next 3Y14.07%
EPS Next 5Y6.54%
Revenue Next Year14.94%
Revenue Next 2Y12.11%
Revenue Next 3Y10.81%
Revenue Next 5Y8.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.25 indicates a reasonable valuation of AMPH.
91.62% of the companies in the same industry are more expensive than AMPH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.73. AMPH is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.04 indicates a reasonable valuation of AMPH.
90.05% of the companies in the same industry are more expensive than AMPH, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, AMPH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.25 | ||
| Fwd PE | 9.04 |
4.2 Price Multiples
AMPH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMPH is cheaper than 89.01% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMPH is valued cheaper than 90.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.13 | ||
| EV/EBITDA | 8.18 |
4.3 Compensation for Growth
AMPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of AMPH may justify a higher PE ratio.
AMPH's earnings are expected to grow with 14.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)0.15
EPS Next 2Y14.54%
EPS Next 3Y14.07%
5. Dividend
5.1 Amount
No dividends for AMPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMPHASTAR PHARMACEUTICALS IN
NASDAQ:AMPH (12/20/2024, 8:00:00 PM)
After market: 39.14 0 (0%)39.14
-0.25 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners72.3%
Inst Owner Change1.37%
Ins Owners8.48%
Ins Owner Change-0.6%
Market Cap1.89B
Analysts80
Price Target58.91 (50.51%)
Short Float %10.99%
Short Ratio10.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.21%
Min EPS beat(2)-4.74%
Max EPS beat(2)19.17%
EPS beat(4)2
Avg EPS beat(4)3.54%
Min EPS beat(4)-6.79%
Max EPS beat(4)19.17%
EPS beat(8)6
Avg EPS beat(8)24.28%
EPS beat(12)9
Avg EPS beat(12)20.04%
EPS beat(16)12
Avg EPS beat(16)23.91%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-3.71%
Max Revenue beat(2)4.61%
Revenue beat(4)1
Avg Revenue beat(4)-0.7%
Min Revenue beat(4)-3.71%
Max Revenue beat(4)4.61%
Revenue beat(8)5
Avg Revenue beat(8)1.14%
Revenue beat(12)8
Avg Revenue beat(12)1.24%
Revenue beat(16)11
Avg Revenue beat(16)1.83%
PT rev (1m)-6.1%
PT rev (3m)-3.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.7%
EPS NY rev (1m)-1.87%
EPS NY rev (3m)-1.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.25 | ||
| Fwd PE | 9.04 | ||
| P/S | 2.62 | ||
| P/FCF | 11.13 | ||
| P/OCF | 9.09 | ||
| P/B | 2.6 | ||
| P/tB | 14.25 | ||
| EV/EBITDA | 8.18 |
EPS(TTM)3.82
EY9.76%
EPS(NY)4.33
Fwd EY11.06%
FCF(TTM)3.52
FCFY8.99%
OCF(TTM)4.31
OCFY11%
SpS14.96
BVpS15.04
TBVpS2.75
PEG (NY)0.51
PEG (5Y)0.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.21% | ||
| ROE | 21.67% | ||
| ROCE | 15.46% | ||
| ROIC | 12.46% | ||
| ROICexc | 15.2% | ||
| ROICexgc | 31.92% | ||
| OM | 29.61% | ||
| PM (TTM) | 21.8% | ||
| GM | 52.98% | ||
| FCFM | 23.52% |
ROA(3y)10.22%
ROA(5y)7.84%
ROE(3y)17.58%
ROE(5y)13.18%
ROIC(3y)11.94%
ROIC(5y)N/A
ROICexc(3y)15.69%
ROICexc(5y)N/A
ROICexgc(3y)24.29%
ROICexgc(5y)N/A
ROCE(3y)14.81%
ROCE(5y)N/A
ROICexcg growth 3Y153.1%
ROICexcg growth 5YN/A
ROICexc growth 3Y93.82%
ROICexc growth 5YN/A
OM growth 3Y114.39%
OM growth 5YN/A
PM growth 3Y276.41%
PM growth 5YN/A
GM growth 3Y10.26%
GM growth 5Y8.62%
F-Score8
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.24 | ||
| Cap/Depr | 72.89% | ||
| Cap/Sales | 5.27% | ||
| Interest Coverage | 7.69 | ||
| Cash Conversion | 78.14% | ||
| Profit Quality | 107.89% | ||
| Current Ratio | 3.43 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.1 |
F-Score8
WACC9.41%
ROIC/WACC1.32
Cap/Depr(3y)104.15%
Cap/Depr(5y)139.84%
Cap/Sales(3y)5.67%
Cap/Sales(5y)7.92%
Profit Quality(3y)96.84%
Profit Quality(5y)392.61%
High Growth Momentum
Growth
EPS 1Y (TTM)21.27%
EPS 3Y72.76%
EPS 5Y70.36%
EPS Q2Q%-16.52%
EPS Next Y20.24%
EPS Next 2Y14.54%
EPS Next 3Y14.07%
EPS Next 5Y6.54%
Revenue 1Y (TTM)20.33%
Revenue growth 3Y22.59%
Revenue growth 5Y16.94%
Sales Q2Q%5.9%
Revenue Next Year14.94%
Revenue Next 2Y12.11%
Revenue Next 3Y10.81%
Revenue Next 5Y8.3%
EBIT growth 1Y18.5%
EBIT growth 3Y162.82%
EBIT growth 5YN/A
EBIT Next Year29.12%
EBIT Next 3Y18.28%
EBIT Next 5Y22.62%
FCF growth 1Y89.5%
FCF growth 3Y83.79%
FCF growth 5YN/A
OCF growth 1Y82.05%
OCF growth 3Y47.43%
OCF growth 5Y36.88%